![Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000997343/2003701320/gr1.gif)
Supplemental Materials for Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet
![Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e00989d3-526c-47d7-8e66-016f9782af61/gr3_lrg.jpg)
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial - The Lancet
![Frauenheim Wengern - Leben, Wohnen, Arbeiten für Menschen mit Behinderungen :: Aktuelles - Plätzchen-Bäckerei Frauenheim Wengern - Leben, Wohnen, Arbeiten für Menschen mit Behinderungen :: Aktuelles - Plätzchen-Bäckerei](http://www.frauenheim-wengern.de/news_2019/pic-aktuelles-831-02.jpg)